MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Sponsored by Surmodics, Inc.
Tackling CLTI From Alternative Access Sites
A conversation with Imraan Ansaarie, MD.
Sponsored by Terumo Interventional Systems
R2P and the OBL Opportunity: Radial-First Hybrid Access for Lower Extremity Intervention
Advancing outpatient endovascular therapy beyond the groin.
By Imraan Ansaarie, MD, FCCP, FSCAI, FSVM
Surmodics’ Sublime Radial Access .018 RX PTA Dilatation Catheter Used in First Clinical Procedures After FDA Clearance
September 29, 2021—Surmodics, Inc. announced the successful first clinical uses of the Sublime radial access .018 RX percutaneous transluminal angioplasty (PTA) dilatation catheter.
A Meeting of Radial Revolutionaries
For a select group of radial-to-peripheral pioneers, September 11-12 marked a turning point.
